Financing co-led by Novo Holdings and the Ljungström family office, with participation from the originator Helsinn, existing ...

"Every day passes by in front of me at breakneck speed.""Before I know it, I'm chased by tasks all day, and at night, I just collapse into bed, completely exhausted."Work, housework, childcare, ...

In my previous article, I spoke about my true feelings: that what I was most afraid of wasn't 'failure itself,' but rather ...

Figure's robots are still in pilots. Its valuation hit $39B. Brett Adcock's partners keep correcting his claims ...

Institutions need space to ask questions; to try — even fail — in the course of their innovation journey.

ZYUS Reports Trichomylin Shows Efficacy Signals In Cancer Pain Trial October 01, 2026 10:51 ET ZYUS Life Sciences (ZYUS.V) reported positive Phase 2a UTOPIA-1 data for Trichomylin in cancer pain. The ...

Jim Kahler’s career is defined by the opportunities he created for students, university academic programs and professional ...

Phase 2 data in adults with atopic dermatitis showed that all three zumilokibart dose regimens met the primary endpoint, with significantly ...

Doctors say clinical trials are needed to understand more after Ed Patrick identified a potential side effect of a Parkinson's drug.

For women who carry pathogenic variants in the BRCA1 or BRCA2 genes, one of the most consequential decisions in preventive ...

In 1999, Ihara Science was on the verge of bankruptcy with ¥5 billion in revenue, ¥3.5 billion in accumulated losses, and ¥2.3 billion in debt.

CEST KDventures AB - Investor News KDventures' portfolio company AnaCardio raises EUR 62.5 million in Series B financing STOCKHOLM, Sweden, September 30, 2026. KDventures AB (Nasdaq Stockholm: KDV) ...